Empire Metals Limited Announces Conditional Sale of 75% of Eclipse Gold Project
LONDON, UNITED KINGDOM / ACCESS Newswire / December 30, 2025 / Empire Metals Limited (AIM:EEE)(OTCQX:EPMLF), the AIM-quoted and OTCQX-traded exploration...
Managing Director Resignation and Board Changes
Blackstone Minerals (BSX:AU) has announced Managing Director Resignation and Board Changes Download the PDF here. This post appeared first on...
Jeffrey Christian: Gold, Silver at Record Prices, Expect Spikes Higher in 2026
Jeffrey Christian, managing partner at CPM Group, shares his outlook for gold and silver in 2026, explaining why he expects...
Rick Rule, Ed Steer, Vince Lanci and More — Our Top 5 Interviews of the Year
Don Durrett: Gold, Silver Price Targets and 15 ‘Must-Own’ Silver Stocks Kicking off the list in the fifth spot is...
Silverco Confirms No Material Change
Silverco Mining Ltd. (TSXV: SICO) (‘Silverco’ or the ‘Company’) announces that at the request of CIRO, Silverco wishes to confirm...
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
VANCOUVER, BC / ACCESS Newswire / December 24, 2025 / Goldgroup Mining Inc. (‘Goldgroup‘ or the ‘Company‘) (TSX-V:GGA)(OTC:GGAZF). Further to...
Canadian Investment Regulatory Organization Trade Resumption – SICO
Trading resumes in: Company: Silverco Mining Ltd. TSX-Venture Symbol: SICO All Issues: Yes Resumption (ET): 9:30 AM CIRO can make...
Steadright Grants Stock Options
(TheNewswire) December 24th, 2025 TheNewswire – Muskoka, Ontario Steadright Critical Minerals Inc. (CSE: SCM,OTC:SCMNF) (‘Steadright’ or the ‘Company’) Board...
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Correction: The conversion price was incorrectly reported as .14/share. The correct price is .165/share Correction: Nextech3D.ai Provides Shareholder Update on...
Biotech Market Forecast: Top Trends for Biotech in 2026
The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy...
